Igc Pharma Inc 's ability to collect accounts receivable sequentially worsen to 5.36, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Igc Pharma Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 68 days, from 16 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 50 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 579, from overall ranking in the first quarter 2026 at 2546.

What is Receivable Turnover Ratio?
What is Igc Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IGC Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter	(Mar 31 2025) IV. Quarter
Y / Y Receivable Change	716.09 %	8.82 %	-95.31 %	-6.82 %	210.71 %
Y / Y Revenue Change	-19.7 %	23.35 %	-53.64 %	20.59 %	11.86 %
Receivable Turnover Ratio (TTM)	5.36	23.44	22.57	5.98	5.71
IGC's Total Ranking	# 579	# 2546	# 2980	# 452	#
Accounts Receivable average collection period days	68	16	16	61	64
Seq. Receivable Change	1818.92 %	8.82 %	-17.07 %	-52.87 %	155.88 %
Seq. Revenue Change	-16.4 %	65.97 %	-41.77 %	-0.61 %	28.4 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 18
Healthcare Sector	# 51
Overall Market	# 579

Receivable Turnover Ratio Statistics
High	Average	Low
37.17	9.33	0.7
(Dec 31 2019)		(Jun 30 2017)

IGC Company Profile • Back to IGC Efficiency Comparisons • Compare IGC Receivables Turnover Ratio to its Competitors

Financial Statements
Igc Pharma Inc 's Accounts Receivable	$ 1 Millions	Visit IGC's Balance sheet
Igc Pharma Inc 's Sales TTM	$ 1 Millions	Visit IGC's Income Statement
Sources of IGC's Revenues		Visit IGC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IGC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IGC's Growth Rates	IGC's Roa	IGC's Inventory Turnover Ratio	IGC's Dividend Comparisons
IGC's Profitability Ratios	IGC's Roi	IGC's Asset Turnover Ratio	IGC's Dividend Growth
IGC's Valuation Ratios	IGC's Roe	IGC's Financial Strength Ratios	IGC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Dexcom Inc	4.25	$ 4,968.800 Millions	$ 1,168.000 Millions
Vericel Corporation	4.18	$ 306.303 Millions	$ 73.289 Millions
Retractable Technologies Inc	4.14	$ 33.488 Millions	$ 8.087 Millions
Apyx Medical Corp	4.14	$ 58.105 Millions	$ 14.035 Millions
Regenxbio Inc	4.13	$ 174.482 Millions	$ 42.238 Millions
Revvity Inc	4.12	$ 2,911.811 Millions	$ 706.371 Millions
Pro dex Inc	4.12	$ 77.548 Millions	$ 18.836 Millions
Stoke Therapeutics Inc	4.12	$ 27.588 Millions	$ 6.704 Millions
Medinotec Inc	4.08	$ 10.247 Millions	$ 2.513 Millions
Amgen Inc	4.07	$ 38,095.000 Millions	$ 9,356.250 Millions
Nexalin Technology Inc	4.07	$ 0.217 Millions	$ 0.053 Millions
Outset Medical Inc	4.06	$ 117.551 Millions	$ 28.959 Millions
Butterfly Network Inc	4.05	$ 112.360 Millions	$ 27.732 Millions
Ironwood Pharmaceuticals inc	4.04	$ 389.316 Millions	$ 96.422 Millions
Pelthos Therapeutics Inc	4.03	$ 43.304 Millions	$ 10.757 Millions
Upstream Bio Inc	4.00	$ 3.158 Millions	$ 0.789 Millions
Skinvisible Inc	4.00	$ 0.020 Millions	$ 0.005 Millions
Xencor Inc	3.99	$ 104.973 Millions	$ 26.335 Millions
Bridgebio Pharma Inc	3.99	$ 713.069 Millions	$ 178.918 Millions
Teva Pharmaceutical Industries Limited	3.92	$ 14,105.000 Millions	$ 3,601.250 Millions
Verrica Pharmaceuticals Inc	3.92	$ 30.321 Millions	$ 7.743 Millions
Teleflex Incorporated	3.90	$ 1,628.534 Millions	$ 417.093 Millions
Iovance Biotherapeutics inc	3.90	$ 324.969 Millions	$ 83.272 Millions
Vanda Pharmaceuticals Inc	3.89	$ 215.721 Millions	$ 55.423 Millions
Immunitybio inc	3.87	$ 165.792 Millions	$ 42.832 Millions
Insight Molecular Diagnostics Inc	3.85	$ 1.670 Millions	$ 0.434 Millions
Tonix Pharmaceuticals Holding Corp	3.83	$ 29.102 Millions	$ 7.594 Millions
Urogen Pharma Ltd	3.82	$ 188.317 Millions	$ 49.239 Millions
Akebia Therapeutics Inc	3.82	$ 219.060 Millions	$ 57.324 Millions
Eyepoint Inc	3.79	$ 2.788 Millions	$ 0.735 Millions

Date modified: 2026-08-16T08:24:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.